2000
DOI: 10.1590/s0066-782x2000000200004
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of persistent rejection with methotrexate in stable patients submitted to heart transplantation

Abstract: Objective -To evaluate the use of methotrexate for the treatment of recurrent rejection in heart transplant recipients. The first heart transplant in Brazil was performed by Zerbini in 1968. Currently heart transplantation represents a well-established therapeutic option for end-stage heart failure that does not respond to medical treatment 1 . MethodsDuring the last decade, cyclosporine and other immunosuppressant drugs produced better survival rates and quality of life for heart transplant recipients by redu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
4
0
1

Year Published

2002
2002
2018
2018

Publication Types

Select...
7
2

Relationship

2
7

Authors

Journals

citations
Cited by 10 publications
(6 citation statements)
references
References 9 publications
1
4
0
1
Order By: Relevance
“…The findings of this study are consistent with previous publications in respect to the effectiveness of transplantation to treat symptoms of end-stage heart failure [2,3,9.11] and in respect to rejection and episodes of infection, which still constitute the greatest cause of morbidity and mortality in the immediate postoperative period [17]. Results of patients operated in Brazil show a 5-year survival of 50% for transplanted patients, 10% lower than the corresponding rates from the USA [18,19].…”
Section: Discussionsupporting
confidence: 92%
“…The findings of this study are consistent with previous publications in respect to the effectiveness of transplantation to treat symptoms of end-stage heart failure [2,3,9.11] and in respect to rejection and episodes of infection, which still constitute the greatest cause of morbidity and mortality in the immediate postoperative period [17]. Results of patients operated in Brazil show a 5-year survival of 50% for transplanted patients, 10% lower than the corresponding rates from the USA [18,19].…”
Section: Discussionsupporting
confidence: 92%
“…There are studies comparing the various immunosuppression regimens; however, more reactivations have been diagnosed with the use of mycophenolate mofetil 280 . Experience with the use of tacrolimus, rapamycin, methotrexate and everolimus has not been published, despite their potential benefit 281 . The following can be used to induce tolerance or to treat a rejection episode: corticosteroids; cyclophosphamide; methotrexate 282,283 ; interleukin-2 receptor antagonists; polyclonal antibodies; monoclonal antibodies; and apheresis.…”
Section: Immunosuppressionmentioning
confidence: 99%
“…In our institution endomyocardial biopsy and Gallium-scintigraphy are the main methods to rejection control and Chagas' disease reactivation after heart transplantation, and research too [31][32][33][34][35][36][37][38][39] . The two-dimensional echocardiography has been used in last 25 years to guide endomyocardial biopsy examination with emphasis in critical patients with cardiomyopathy or after heart transplantation; to help in the visualization of the intracardiac tumors' position and in patients that cannot go at catheterization room 40,41 .…”
Section: Disadvantagesmentioning
confidence: 99%